Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): A novel mechanism for the control of FGF-2 and thrombin activity

Oncogene

Volumn 27, Issue 18, 2008, Pages 2594-2601

  Yu, P J ^a   Ferrari, G ^a   Pirelli, L ^a   Galloway, A C ^a   Mignatti, P ^a   Pintucci, G ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial cells; Inflammation; Migration; Proliferation; Proteolysis; Serine proteinases

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; THROMBIN;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM CELL; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; INFLAMMATION MEDIATORS; MICE; MOLECULAR WEIGHT; PROTEIN PROCESSING, POST-TRANSLATIONAL; THROMBIN; TRANSCRIPTION, GENETIC;

EID: 42249099989     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210899     Document Type: Article

References (40)

1. Arai T, Guo JP, McGeer PL. (2005). Proteolysis of non-phosphorylated and phosphorylated tau by thrombin. J Biol Chem 280: 5145-5153.
2. Balcaitis S, Xie Y, Weinstein JR, Andersen H, Hanisch UK, Ransom BR et al. (2003). Expression of proteinase-activated receptors in mouse microglial cells. NeuroReport 14: 2373-2377.
3. Bikfalvi A, Klein S, Pintucci G, Quarto N, Mignatti P, Rifkin DB. (1995). Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms. J Cell Biol 129: 233-243.
4. Burgess WH, Bizik J, Mehlman T, Quarto N, Rifkin DB. (1991). Direct evidence for methylation of arginine residues in high molecular weight forms of basic fibroblast growth factor. Cell Regul 2: 87-93.
5. Claus P, Werner S, Timmer M, Grothe C. (2004). Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease. Neurosci Lett 360: 117-120.
6. Coughlin SR. (2005). Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3: 1800-1814.
7. Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, Haber DA et al. (1998). Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16: 1217-1222.
8. Cucina A, Borrelli V, Lucarelli M, Sterpetti AV, Cavallaro A, Strom R et al. (2002). Autocrine production of basic fibroblast growth factor translated from novel synthesized mRNA mediates thrombin-induced mitogenesis in smooth muscle cells. Cell Biochem Funct 20: 39-46.
9. Daniel TO, Gibbs VC, Milfay DF, Garovoy MR, Williams LT. (1986). Thrombin stimulates c-sis gene expression in microvascular endothelial cells. J Biol Chem 261: 9579-9582.
10. Ding L, Donate F, Parry GC, Guan X, Maher P, Levin EG. (2002). Inhibition of cell migration and angiogenesis by the amino-terminal fragment of 24kD basic fibroblast growth factor. J Biol Chem 277: 31056-31061.
11. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y et al. (1998). Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 4: 909-914.
12. Ferrari G, Pintucci G, Seghezzi G, Hyman K, Galloway AC, Mignatti P. (2006). VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc Natl Acad Sci USA 103: 17260-17265.
13. Florkiewicz RZ, Sommer A. (1989). Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc Natl Acad Sci USA 86: 3978-3981.
14. Herbert JM, Dupuy E, Laplace MC, Zini JM, Bar Shavit R, Tobelem G. (1994). Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. Biochem J 303(Part 1): 227-231.
15. Ishibashi T, Sakamoto T, Ohkawara H, Nagata K, Sugimoto K, Sakurada S et al. (2003). Integral role of RhoA activation in monocyte adhesion-triggered tissue factor expression in endothelial cells. Arterioscler Thromb Vasc Biol 23: 681-687.
16. Itoh N, Ornitz DM. (2004). Evolution of the Fgf and Fgfr gene families. Trends Genet 20: 563-569.
17. Klein S, Bikfalvi A, Birkenmeier TM, Giancotti FG, Rifkin DB. (1996). Integrin regulation by endogenous expression of 18-kDa fibroblast growth factor-2. J Biol Chem 271: 22583-22590.
18. Klein S, Carroll JA, Chen Y, Henry MF, Henry PA, Ortonowski IE et al. (2000). Biochemical analysis of the arginine methylation of high molecular weight fibroblast growth factor-2. J Biol Chem 275: 3150-3157.
19. Lobb RR. (1988). Thrombin inactivates acidic fibroblast growth factor but not basic fibroblast growth factor. Biochemistry 27: 2572-2578.
20. Malecki J, Wesche J, Skjerpen CS, Wiedlocha A, Olsnes S. (2004). Translocation of FGF-1 and FGF-2 across vesicular membranes occurs during G1-phase by a common mechanism. Mol Biol Cell 15: 801-814.
21. Mann KG. (2003). Thrombin: can't live without it; probably die from it. Chest 124: 1S-3S.
22. Mignatti P, Morimoto T, Rifkin DB. (1991). Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc Natl Acad Sci USA 88: 11007-11011.
23. O'Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, Woulfe DS et al. (2000). Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem 275: 13502-13509.
24. Ornitz DM, Itoh N. (2001). Fibroblast growth factors. Genome Biol 2, REVIEWS3005.
25. Papadimitriou E, Manolopoulos VG, Hayman GT, Maragoudakis ME, Unsworth BR, Fenton II JW et al. (1997). Thrombin modulates vectorial secretion of extracellular matrix proteins in cultured endothelial cells. Am J Physiol 272: C1112-C1122.
26. Pintucci G, Moscatelli D, Saponara F, Biernacki PR, Baumann FG, Bizekis C et al. (2002). Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J 16: 598-600.
27. Pintucci G, Quarto N, Rifkin DB. (1996). Methylation of high molecular weight fibroblast growth factor-2 determines post-translational increases in molecular weight and affects its intracellular distribution. Mol Biol Cell 7: 1249-1258.
28. Piotrowicz RS, Martin JL, Dillman WH, Levin EG. (1997). The 27-kDa heat shock protein facilitates basic fibroblast growth factor release from endothelial cells. J Biol Chem 272: 7042-7047.
29. Prats H, Kaghad M, Prats AC, Klagsbrun M, Lelias JM, Liauzun P et al. (1989). High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc Natl Acad Sci USA 86: 1836-1840.
30. Quarto N, Fong KD, Longaker MT. (2005). Gene profiling of cells expressing different FGF-2 forms. Gene 356: 49-68.
31. Rauch BH, Millette E, Kenagy RD, Daum G, Clowes AW. (2004). Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells. Circ Res 94: 340-345.
32. Rauch BH, Millette E, Kenagy RD, Daum G, Fischer JW, Clowes AW. (2005). Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells. J Biol Chem 280: 17507-17511.
33. Rickles FR, Patierno S, Fernandez PM. (2003). Tissue factor, thrombin, and cancer. Chest 124: 58S-68S.
34. Sharony R, Pintucci G, Saunders PC, Grossi EA, Baumann FG, Galloway AC et al. (2006). Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2. Am J Physiol Heart Circ Physiol 290: H1651-H1659.
35. Sorensen V, Nilsen T, Wiedlocha A. (2006). Functional diversity of FGF-2 isoforms by intracellular sorting. BioEssays 28: 504-514.
36. Taverna S, Ghersi G, Ginestra A, Rigogliuso S, Pecorella S, Alaimo G et al. (2003). Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. J Biol Chem 278: 51911-51919.
37. Touriol C, Bornes S, Bonnal S, Audigier S, Prats H, Prats AC et al. (2003). Generation of protein isoform diversity by alternative initiation of translation at non-AUG codons. Biol Cell 95: 169-178.
38. Tsopanoglou NE, Maragoudakis ME. (1999). On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J Biol Chem 274: 23969-23976.
39. Vagner S, Gensac MC, Maret A, Bayard F, Amalric F, Prats H et al. (1995). Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol Cell Biol 15: 35-44.
40. Yu PJ, Ferrari G, Galloway AC, Mignatti P, Pintucci G. (2007). Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age. J Cell Biochem 100: 1100-1108.